Professor, Internal Medicine, Yale University School of Medicine
Cardiology
Dr. Lawrence H. Young, MD
|
|
Give Review
Dr. Lawrence H. Young practices Cardiology. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Top MD". Doctor Lawrence H. Young, MD has written publications. He has 47 publications published with PubMed. The lastest paper is: 'miR-182 Modulates Myocardial Hypertrophic Response Induced by Angiogenesis in Heart.' Dr. Lawrence H. Young accepts Medicare payments and is listed with Medicare.gov.
Publications
- AMPK is critical for mitochondrial function during reperfusion after Myocardial ischemia.
- Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the Heart.
- The Heart rate response to adenosine: A simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes.
- Bevacizumab: finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiEctasia.
- Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor-AMP-Activated Protein Kinase Signal Transduction.
- Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: Results from the DIAD study.
- AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase-3β (GSK-3β) inhibition induce Ca2+-independent deposition of tight junction components at...
- A small molecule AMPK activator protects the Heart against ischemia-reperfusion injury.
- Risk stratification in diabetes: not all patients or perfusion Defects are the same.
- Diet-induced obesity obstructs insulin signaling in the Heart.
- Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.
- Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study.
- A crystallized view of AMPK activation.
- AMP-activated protein kinase conducts the ischemic stress response orchestra.
- Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse Heart.
- Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis.
- Diabetes mellitus and cardiovascular Disease.
- AMP-activated protein kinase regulates the assembly of epithelial tight junctions.
- Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat Heart.
- Value of peripheral vascular endothelial function in the detection of relative Myocardial ischemia in asymptomatic type 2 diabetic patients who underwent Myocardial pe...
- AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic Heart.
- AMP-activated protein kinase: a key stress signaling pathway in the Heart.
- Dual mechanisms regulating AMPK kinase action in the ischemic Heart.
- Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic Syndrome.
- Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in Heart muscle.
- Brachial Artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachi...
- Diastolic function and type 1 diabetes.
- AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.
- Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic Heart.
- Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration.
- Thiazolidinedione use, fluid retention, and congestive Heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
- Insulin resistance and the effects of thiazolidinediones on cardiac metabolism.
- Physiological role of AMP-activated protein kinase in the Heart: graded activation during exercise.
- Diagnosis of CAD in patients with diabetes: who to evaluate.
- AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to Chronic energy deprivation.
- Cardiac outcomes after Myocardial infarction in elderly patients with diabetes mellitus.
- Acute myocardial infarction in the elderly with diabetes.
- Correlation of Myocardial p-(123)I-iodophenylpentadecanoic acid retention with (18)F-FDG accumulation during experimental low-flow ischemia.
- miR-182 Modulates Myocardial Hypertrophic Response Induced by Angiogenesis in Heart.
- Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis.
- Thiazolidinedione use, fluid retention, and congestive Heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Octo...
- Detection of silent Myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.
- Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic Heart.
- Screening for Coronary artery disease in patients with diabetes.
- Resolution of asymptomatic Myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.
- Cardiac outcomes after screening for asymptomatic Coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.
Schools
Yale University School Of Medicine
Yale New Haven Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Connecticare HMO
- Connecticare POS
- CoreSource
- Health Insurance Plan of Greater New York (HIP) PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1932199387 | |
| NPPES Provider LastName | YOUNG | |
| NPPES Provider FirstName | LAWRENCE | |
| NPPES Provider ZIPCode | 065191304 | |
| NPPES Provider State | CT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2479.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 37.0 | |
| Percent Opioid Claims | 1.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932199387 |
| Last Name Of The Provider | YOUNG |
| First Name Of The Provider | LAWRENCE |
| View All |
Similar Doctors
|
|
Dr. Hitender Jain, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Ardesia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Foley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harlan M. Krumholz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Oliver J. Wang, MD
This Doctor is OpenDoctor Recommended.
|